semaglutide 4 units Wegovy® 2.4 mg / 0.75 mL Injection Wegovy Semaglutide 2.4mg/0.75ml Injection Prefilled

As presented at the American Diabetes Association Meeting: this randomized phase 2b trial in 230 adults with overweight or obesity shows that aleniglipron, an oral small-molecule GLP1-RA, led to up to 11.3% body-weight loss compared with placebo after 36 weeks of treatment.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research into its broader health impacts.

Join me this Friday for a live conversation with Equinox personal trainer, Jabari Arnold, as we discuss our approach to managing clients on GLP1s

Did you buy GLP-1 products from Fridays

You may be a candidate for Botox

How Do You Say